Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Baxter Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 17
Rounds per year 1.64
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Exits 8
Key employees 2

Areas of investment

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical
  • Medical Device
Summary

The main department of described VC is located in the Deerfield. The fund was located in North America if to be more exact in United States. Baxter Ventures seemed to be an CVC arrangement as part of the organization.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Baxter Ventures performs on 18 percentage points more the average number of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The top activity for fund was in 2015.

We also calculated 2 valuable employees in our database.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Fitness. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight VitalConnect, Covagen, SANIFIT.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Baxter Ventures, startups are often financed by Warburg Pincus, The Vertical Group, Perceptive Advisors. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Sante Ventures, SR One. In the next rounds fund is usually obtained by SR One, OrbiMed, MPM Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Baxter Ventures:
Typical Co-investors
Baxter Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Baxter Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AV Labs Austin, Texas, United States
Bay Wharf Capital -
China COSCO SHIPPING China, Shanghai
Cygnus Montanus Trust -
Eleven Bulgaria, Grad Sofiya, Sofia
Envoi Ventures New York, Rochester, United States
Imperial College Business School England, London, United Kingdom
Konza Valley Capital Kansas, Leawood, United States
KTH Holding Stockholm, Stockholm County, Sweden
LJH Partners New York, New York, United States
Manufacturing Resources International Georgia, Louisiana, United States
Patient-Centered Outcomes Research Institute District of Columbia, United States, Washington
PCI-Suntek Technology China, Guangdong, Guangzhou
Phillips Publishing Maryland, Potomac, United States
Phoenix Mills -
Shenzhen Huijing Tongda Business Consulting China, Guangdong, Shenzhen
SHIFT Japan, Tokyo
Simon School of Business, University of Rochester New York, Rochester, United States
Tianchuang Zhixing (Beijing) Touzi Guanli Zixun Youxian Gongsi Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hospital IQ

Analytics
Health Care
Software
$25M28 Jun 2021 Newton, Massachusetts, United States

Medasense

Artificial Intelligence
Biometrics
Health Care
Medical
Medical Device
Sensor
$18M22 Sep 2020 Israel, Tel Aviv District, Israel

Fitness
Health Care
$10M28 Nov 2018 Mountain View, California, United States

VitalConnect

Analytics
Biotechnology
Health Care
Medical Device
Wearables
$38M31 Oct 2017 San Jose, California, United States

Kit Check

Enterprise Software
Health Care
Information Technology
Software
$20M20 Jun 2016 Washington, District of Columbia, United States

Opsonix

Biotechnology
Health Care
Medical
Therapeutics
$8M08 Oct 2015 Cambridge, Massachusetts, United States

TVA Medical

Health Care
Medical Device
Therapeutics
$15M06 Oct 2015 Austin, Texas, United States

SANIFIT

Biotechnology
Hospital
Medical
$43M08 Sep 2015 Palma De Mallorca, Islas Baleares, Spain

Precision BioSciences

Biotechnology
Genetics
Health Care
Medical
$25M11 May 2015 Durham, North Carolina, United States
News
Hospital IQ Raises $25 Million to Meet Market Demand for its Software which Optimizes Health System Operations

– Hospital IQ secured $25m in Series C funding led by Baxter Ventures, the venture investment arm of Baxter International Inc., and Health Velocity Capital, joining existing investors Pierpoint Capital and Allscripts.
– The investment comes amid a year of unprecedented company growth as its AI-enabled operations management platform solved operational inefficiencies, many of which were exacerbated by the pandemic, for hundreds of hospitals and health systems.
– Hospital IQ will use the funding to accelerate growth across all areas of the company, including product development, sales and marketing, and client services, and to spur further collaboration with its existing Allscripts and Cerner partnerships, as well as support new partnerships.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Baxter Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 18
Average round size 38M
Rounds per year 1.64
Peak activity year 2015
Lead investments 3
Follow on index 0.06
Exits 8
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Hospital IQ

Analytics
Health Care
Software
$25M28 Jun 2021 Newton, Massachusetts, United States

Medasense

Artificial Intelligence
Biometrics
Health Care
Medical
Medical Device
Sensor
$18M22 Sep 2020 Israel, Tel Aviv District, Israel

Fitness
Health Care
$10M28 Nov 2018 Mountain View, California, United States

VitalConnect

Analytics
Biotechnology
Health Care
Medical Device
Wearables
$38M31 Oct 2017 San Jose, California, United States

Kit Check

Enterprise Software
Health Care
Information Technology
Software
$20M20 Jun 2016 Washington, District of Columbia, United States

Opsonix

Biotechnology
Health Care
Medical
Therapeutics
$8M08 Oct 2015 Cambridge, Massachusetts, United States

TVA Medical

Health Care
Medical Device
Therapeutics
$15M06 Oct 2015 Austin, Texas, United States

SANIFIT

Biotechnology
Hospital
Medical
$43M08 Sep 2015 Palma De Mallorca, Islas Baleares, Spain

Precision BioSciences

Biotechnology
Genetics
Health Care
Medical
$25M11 May 2015 Durham, North Carolina, United States
Crunchbase icon

Content report

The following text will be sent to our editors: